BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹16 Cr | ₹13 Cr | ₹9.65 Cr | ₹6.17 Cr | ₹5.39 Cr |
What is the latest Total Non-Current Liabilities ratio of BAFNA PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹9.65 Cr |
| Mar2022 | ₹6.17 Cr |
| Mar2021 | ₹5.39 Cr |
How is Total Non-Current Liabilities of BAFNA PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | 28.69 | |
| Mar2024 | ₹13 Cr | 32.20 | |
| Mar2023 | ₹9.65 Cr | 56.49 | |
| Mar2022 | ₹6.17 Cr | 14.52 | |
| Mar2021 | ₹5.39 Cr | - | |
Compare Total Non-Current Liabilities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹372.3 Cr | 7.6% | -9.9% | 76.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,131.0 Cr | -0.7% | -0.5% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,862.0 Cr | 2.8% | 2.2% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,254.0 Cr | 1.5% | 3.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹121,198.0 Cr | 0.8% | 0.1% | 3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,083.0 Cr | 0.4% | 3.2% | 0.3% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 7.6% |
-9.9% |
76.4% |
| SENSEX | 0.4% |
-0.1% |
6.1% |
You may also like the below Video Courses